Xiuxiu Wang

  • Postdoctoral Associate

Research interests focus on design of multi-functional nanocarriers for targeted drug delivery

Tiny Capsules Packed with Gene-Editing Tools Offer Alternative to Viral Delivery of Gene Therapy

An interdisciplinary pair of WID researchers has developed a new nanocapsule delivery method for delivering the CRISPR-Cas9 gene editing tool. The new system could be used for many types of gene therapies.

Min Wu

Min Wu

  • Visiting Scholar

Drug delivery

Shivani Saxena

  • Graduate Student

Engineering cells and organism via genome editing and studying the delivery method for CRISPR/Cas9

Yanpei Fei

  • Visiting Scholar

Polymer processing and foaming which apply to acoustic damping and electromagnetic shielding

Xingxing Shi

Xingxing Shi

  • Visiting Scholar

Multifunctional polymer nanocomposites for various applications

Shengrui Yu

  • Visiting Professor

Injection molding process control / Micro-cellular foaming molding

Jingxian Jiang

Jingxian Jiang

  • Graduate Student

Biomass aerogels' preparation and application investigation

Sheng Chen

Sheng Chen

  • Graduate Student

Biomass-based functional materials for applications in flexible electronics and energy.

Yi Zhao

Yu Zhao

  • Postdoctoral Associate

Drug delivery nanoparticles for vascular diseases.

Min Zhu

MIn Zhu

  • Graduate Student

Nanoparticles for delivery of therapeutic agents and with gene-editing

Randolph Ashton Continues Research into Causes of Lou Gehrig’s Disease

In August 2017, Randolph Ashton received almost $800,000 from the National Institute of Neurological Disorders and Stroke, part of NIH, to continue a five-year research study of Lou Gehrig’s disease (amyotrophic lateral sclerosis, or ALS), after successfully completing its first phase.

UW-Madison to be Partner in Center for Cell Manufacturing Technologies

The National Science Foundation has awarded nearly $20 million to a consortium of universities to support a new engineering research center that will develop transformative tools and technologies for the consistent, scalable, and low-cost production of high-quality living therapeutic cells. Several WID investigators are collaborators on the project.

Nisakorn Yodsanit

Nisakorn Yodsanit

  • Graduate Student

Nanomedicine or nanomaterials for biomedical applications.